Cargando…

FABP1 controls hepatic transport and biotransformation of Δ(9)-THC

The increasing use of medical marijuana highlights the importance of developing a better understanding of cannabinoid metabolism. Phytocannabinoids, including ∆(9)-tetrahydrocannabinol (THC), are metabolized and inactivated by cytochrome P450 enzymes primarily within the liver. The lipophilic nature...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elmes, Matthew W., Prentis, Lauren E., McGoldrick, Luke L., Giuliano, Christopher J., Sweeney, Joseph M., Joseph, Olivia M., Che, Joyce, Carbonetti, Gregory S., Studholme, Keith, Deutsch, Dale G., Rizzo, Robert C., Glynn, Steven E., Kaczocha, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527858/ https://www.ncbi.nlm.nih.gov/pubmed/31110286 http://dx.doi.org/10.1038/s41598-019-44108-3

Ejemplares similares

FABP5 coordinates lipid signaling that promotes prostate cancer metastasis
por: Carbonetti, Gregory, et al.
Publicado: (2019)

Identification of Fatty Acid Binding Protein 5 Inhibitors Through Similarity-Based Screening
por: Zhou, Yuchen, et al.
Publicado: (2019)

Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs
por: Berger, William T., et al.
Publicado: (2012)

Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms
por: Peng, Xiaoxue, et al.
Publicado: (2017)

FABP5 deletion in nociceptors augments endocannabinoid signaling and suppresses TRPV1 sensitization and inflammatory pain
por: Bogdan, Diane M., et al.
Publicado: (2022)

Proteomic analysis of signaling pathways modulated by FABP5 in macrophages
por: Doswell, Faniya, et al.
Publicado: (2023)

Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
por: Gasse, Angela, et al.
Publicado: (2020)

Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation
por: Leung, KwanNok, et al.
Publicado: (2013)

Acute human exposure assessment to tetrahydrocannabinol (Δ(9)‐THC)
por: Arcella, Davide, et al.
Publicado: (2020)

Incarvillateine produces antinociceptive and motor suppressive effects via adenosine receptor activation
por: Kim, Jinwoo, et al.
Publicado: (2019)

Nanomaterials-Based Electrochemical Δ(9)-THC and CBD Sensors for Chronic Pain
por: Pazuki, Dadbeh, et al.
Publicado: (2023)

Study of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extraction FROM dried oral fluid spots (DOFS) and LC–MS/MS detection
por: Gorziza, Roberta, et al.
Publicado: (2021)

Default Mode Network in the Effects of Δ9-Tetrahydrocannabinol (THC) on Human Executive Function
por: Bossong, Matthijs G., et al.
Publicado: (2013)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2020)

The Dark Side of Cannabidiol: The Unanticipated Social and Clinical Implications of Synthetic Δ(8)-THC
por: Geci, Michael, et al.
Publicado: (2023)

Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
por: Boonyayothin, Wanuttha, et al.
Publicado: (2022)

A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
por: Deutsch, Dale G.
Publicado: (2016)

Highway to hell or magic smoke? The dose-dependence of Δ(9)-THC in place conditioning paradigms
por: Kubilius, Rimas A., et al.
Publicado: (2018)

Genetic Modulation of Initial Sensitivity to Δ9-Tetrahydrocannabinol (THC) Among the BXD Family of Mice
por: Parks, Cory, et al.
Publicado: (2021)

Effects of Δ9-Tetrahydrocannibinol (THC) on Obesity at Different Stages of Life: A Literature Review
por: Fearby, Nathan, et al.
Publicado: (2022)

The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice
por: Eitan, Adi, et al.
Publicado: (2023)

Chronic Δ(9)-THC Exposure Differently Affects Histone Modifications in the Adolescent and Adult Rat Brain
por: Prini, Pamela, et al.
Publicado: (2017)

Δ(9)-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial
por: Adam, Kirsten C. S., et al.
Publicado: (2020)

Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study
por: Reece, Albert Stuart, et al.
Publicado: (2022)

Measurement of Δ(9)THC and metabolites in the brain and peripheral tissues after intranasal instillation of a nanoformulation
por: Upadhyay, Gunjan, et al.
Publicado: (2023)

Delta-8-THC: Delta-9-THC’s nicer younger sibling?
por: Kruger, Jessica S., et al.
Publicado: (2022)

Multi-laboratory validation of a Δ9-tetrahydrocannabinol LC-MS/MS test kit designed for quantifying THC and marijuana metabolites in blood
por: Patton, Amy L, et al.
Publicado: (2018)

A Critical Review of the Role of the Cannabinoid Compounds Δ(9)-Tetrahydrocannabinol (Δ(9)-THC) and Cannabidiol (CBD) and their Combination in Multiple Sclerosis Treatment
por: Jones, Éamon, et al.
Publicado: (2020)

The Cannabinoids Δ(8)THC, CBD, and HU-308 Act via Distinct Receptors to Reduce Corneal Pain and Inflammation
por: Thapa, Dinesh, et al.
Publicado: (2018)

Development and validation of an automated liquid-liquid extraction GC/MS method for the determination of THC, 11-OH-THC, and free THC-carboxylic acid (THC-COOH) from blood serum
por: Purschke, Kirsten, et al.
Publicado: (2016)

Antitumor effects of THC.
por: Huff, J, et al.
Publicado: (2000)

Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia
por: Kaczocha, Martin, et al.
Publicado: (2014)

Δ(9)-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles
por: Williams, Julie C., et al.
Publicado: (2015)

Possible roles of AMPK and macropinocytosis in the defense responses against Δ(9)-THC toxicity on HL-1 cardiomyocytes
por: Murata, Tatsuhiko, et al.
Publicado: (2021)

FABP1 and FABP2 as markers of diabetic nephropathy
por: Tsai, I-Ting, et al.
Publicado: (2020)

Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
por: Afrin, Farjana, et al.
Publicado: (2020)

The safety of lookalikes: a new THC beverage enhancer and a non-THC counterpart
por: Brown, Geoffrey W., et al.
Publicado: (2023)

CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ(9)-Tetrahydrocannabinol (Δ(9)-THC)-Induced Aversive Effects in Mice
por: Han, Xiao, et al.
Publicado: (2017)

Chronic low-dose Δ(9)-tetrahydrocannabinol (THC) treatment stabilizes dendritic spines in 18-month-old mice
por: Komorowska-Müller, Joanna Agnieszka, et al.
Publicado: (2023)

Chronic exposure to inhaled vaporized cannabis high in Δ9-THC alters brain structure in adult female mice
por: Taylor, Autumn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jjk004gc0vscfsnndegpr9v84e